Plain-English translation of NCT06264700 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Sickle Cell Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether video check-ins — where you show a provider that you're taking your hydroxyurea as prescribed — can help young people with sickle cell disease stick with their medication. Half of participants will use video check-ins for six months, while the other half will receive regular check-ins by phone and text. Everyone will be given a smartphone to use during the study.
Many people with sickle cell disease struggle to take their medication regularly, which can lead to more pain, hospitalizations, and other serious complications. This trial is testing whether video check-ins make it easier and more sustainable to stay on track with this treatment.
After a short run-in period, you'll be randomly assigned to either the video check-in group or the phone/text check-in group. If you're in the video check-in group, you'll use an app to record videos showing that you're taking your medication at your scheduled times for six months. After that six-month period, you'll continue being monitored for another six months with monthly phone calls and text messages. Throughout the study, a device will track when you open your medication bottle, and researchers will measure how well the different approaches work using surveys and your medical records.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States